IP Library › Patent Application 12253667
Patent Application
App. No. 12/253,667

METHOD FOR AMELIORATING OF POST-ANESTHETIC RECOVERY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/253,667
Abstract

The invention describes use of injectable form of Idebenone to improve recovery after general anesthesia and of cognitive functions, suppress disorientation and other signs of neuronal damage.

Claims (7)

1 . Method of treatment or prevention of post-operative cognitive dysfunction (POCD) syndrome or delirium and improvement in post-anesthesia recovery by the parenteral administration of a pharmaceutical composition, comprising at least one physiologically acceptable ubiquinone.

2 - 6 . (canceled)

7 . A method as set forth in claim 1 wherein said ubiquinone is 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (Idebenone).

8 . A method as set forth in claim 1 wherein said composition is administrated parenterally via intravenous injection, intravenous infusion, intra-arterial, intramuscular, subcutaneous or intra-peritoneal injection.

9 . A method as set forth in claim 7 wherein said Idebenone is administrated in doses from 0.5 to 50 mg/kg per day.

10 . A method as set forth in claim 1 wherein said composition is a colloidal delivery system, selected from micellar preparations, emulsions, solid lipid nanoparticles or suspensions, wherein said ubiquinone is associated with the hydrophobic phase of the colloidal system.

11 . A method as set forth in claim 10 wherein said colloidal delivery system is an oil-in-water emulsion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 9, 2010
From: SCHWARZ, JOSEPH; WEISSPAPIR, MICHAEL
To: ALPHARX INC
Reel/Frame 024660/0013 →